ASCO 2023

Join us in our excitement as we return to the 2023 ASCO annual meeting this June. ASCO allows Catalyst Clinical Research to share its innovative clinical research solutions with stakeholders in the greater cancer research industry. The ASCO conference promotes connectivity among oncology professionals and leading cancer researchers to share new developments in clinical advances in cancer research and oncology treatments. The 2023 ASCO theme will focus on positive patient outcomes, titled “Partnering with Patients: The Cornerstone of Cancer Care and Research.” Because the oncology industry is ever-changing in research and clinical trial outcomes, this collaborative event of industry leaders is not to be missed. Follow our social media tag #Catalyst@ASCO for live daily updates from our team on our LinkedIn and Twitter. 

We will be proudly hosting booth #21171 to share resources and information on the clinical trial solutions Catalyst provides through extensive experience and a flexible, client-focused approach. Stop by to learn more about our Catalyst Flex sector for multi-therapeutic global resourcing and CRO services, and our Catalyst Oncology sector committed to developing next-generation therapies for cancer patients. ASCO gives us the opportunity to share the heart of Catalyst Clinical Research in front of fellow advocates for cancer patients in need: inspiring people to design and deliver better clinical trials. Learn more about our clinical research solutions on our website.  

We hope to see everyone at the event and look forward to sharing our commitment to high quality clinical research trials, supported by our proud Catalyst Clinical Research representatives. Attendees include Amy Nguyen, Andrew Zupnick, Christine Lys, Erin Tabet, Jason Lackey, Kevin Wightman, Keya Watkins, Lisa Hornick, Megan Collett, Melissa Hill, Nick Dyer, Nik Morton, Sue Albert, and Frankie Durrant.